Background
IV iron is used for the treatment of iron deficiency anemia when oral iron is effective or not tolerated.
Formulations available in the United States include low-molecular-weight iron dextran (LWMID), ferric gluconate, iron sucrose, ferumoxytol, iron isomaltoside, and ferric carboxymaltose.
High-molecular weight iron dextrans were discontinued in the United States due to having a higher rate of hypersensitivity reactions.
Minor Infusion Reactions
Symptoms of minor infusion reactions to IV iron includeâflushing, chest/back tightness, myalgiasâand, importantly, do not have any features of anaphylaxis.
Labile, or also called âfree,â iron is associated with minor infusion reactions to IV iron.
Skin Testing
As most hypersensitivity reactions are non-IgE-mediatedârather via CARPAâskin testing has limited utility for evaluating IV iron hypersensitivity reactions; however, it may help detect the rare patients with IgE-mediated hypersensitivity.
Management
Approaches for patients with history of mild to moderate IV iron reactions include: switching to an alternative IV iron formulation, slowing the infusion rate (e.g., 10% of recommended rate during the first 10 to 15 minutes), and/or pre-treatment with non-sedating, second generation antihistamines.
For patients with a history of anaphylactic reactions to IV iron, desensitization can be considered, such as ferric gluconate.
References
GĂłmez-RamĂrez S, Shander A, Spahn DR, et al. Prevention and management of acute reactions to intravenous iron in surgical patients. Blood Transfusion. Published online April 10, 2019. doi:10.2450/2018.0156-18
Muñoz M, GĂłmez-RamĂrez S, Bhandari S. The safety of available treatment options for iron-deficiency anemia. Expert Opin Drug Saf 2018; 17: 149-59.